Sun Pharma denies USD 10 billion Organon acquisition news as speculative

Strategic Transactions View source PDF Explain this filing

SUNPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.2%Reaction day

₹1674.90

prior close

₹1641.40

announcement price

In-mkt

timing

Nifty 100market · index membership as recorded later (tracked since Jun 2026)-1.5%-1.7% vs market

Pharmaceuticals peers, median of 157sector-2.1%-1.1% vs sector

On the reaction day the stock moved 1.7 pts less than Nifty 100 and 1.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

-0.1

15m

+0.0

30m

-0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-3.2-1.5-1.7-2.1-1.1

Next day

-3.6-1.8-1.7-3.4-0.2

-2.4-1.2-1.1-2.0-0.4

-2.5-2.3-0.2-3.4+0.9

-2.1-1.8-0.3-3.5+1.4

-4.0-0.9-3.1-3.2-0.8

-4.8-1.1-3.7-2.2-2.6

15d

+1.9+1.6+0.3+1.0+0.9

+2.9+0.1+2.8-1.8+4.7

+5.7-9.2+14.9-8.0+13.7

-0.5-3.5+3.0-0.1-0.4

UpDownMarket · Nifty 100Sector · Pharmaceuticals peers, median of 157Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

NSE asked Sun Pharma to clarify a news18.com article claiming the company was acquiring Organon for USD 10 billion to strengthen its US presence. Sun Pharma called the news speculative and said no material event requires disclosure under Listing Regulations. A similar clarification was filed with BSE on the previous day.

Likely market impact

Rumor denied by the company. No confirmed acquisition. Stock may see volatility from unconfirmed media reports.